Maki Takeda
Suita, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Human induced pluripotent stem cell-derived cardiomyocyte patch enhances cardiac regeneration in a J2N-k hamster model of dilated cardiomyopathy.
Journal: Regenerative therapy
Published: March 31, 2026
Stable and functional regulatory T cell attenuates fibrotic remodeling in heart failure.
Journal: Regenerative therapy
Published: October 28, 2025
Systemic administration of induced pluripotent stem cell-derived mesenchymal stem cells improves cardiac function through extracellular vesicle-mediated tissue repair in a rat model of ischemic cardiomyopathy.
Journal: Regenerative therapy
Published: October 27, 2024
Gene correction and overexpression of TNNI3 improve impaired relaxation in engineered heart tissue model of pediatric restrictive cardiomyopathy.
Journal: Development, growth & differentiation
Published: December 10, 2023
Human induced pluripotent stem cell-derived closed-loop cardiac tissue for drug assessment.
Journal: iScience
Published: September 05, 2023
Estimation of crossbridge-state during cardiomyocyte beating using second harmonic generation.
Journal: Life science alliance
Published: April 02, 2023
Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports.
Journal: Frontiers in cardiovascular medicine
Published: March 08, 2023
Pleiotropic effects of extracellular vesicles from induced pluripotent stem cell-derived cardiomyocytes on ischemic cardiomyopathy: A preclinical study.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: February 27, 2023
Establishment of a protocol to administer immunosuppressive drugs for iPS cell-derived cardiomyocyte patch transplantation in a rat myocardial infarction model.
Journal: Scientific reports
Published: January 31, 2023
Pre-clinical evaluation of the efficacy and safety of human induced pluripotent stem cell-derived cardiomyocyte patch.
Journal: Stem cell research & therapy
Published: September 22, 2022
Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for TNNT2 Δ160E-Induced Cardiomyopathy.
Journal: Circulation. Genomic and precision medicine
Published: July 21, 2022
Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy.
Journal: Frontiers in cardiovascular medicine
Published: May 23, 2022
Last Updated: 09/26/2026